XML 17 R2.htm IDEA: XBRL DOCUMENT v3.25.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Jan. 31, 2025
Jan. 31, 2024
Income Statement [Abstract]        
Net sales $ 67,167 $ 46,778 $ 163,324 $ 147,053
Cost of products sold 48,788 34,749 118,505 109,642
Gross profit 18,379 12,029 44,819 37,411
Operating expenses 16,129 8,223 35,560 24,688
Operating profit 2,250 3,806 9,259 12,723
Pension expense 0 (41) 0 (122)
Other income, net 162 161 428 384
Interest expense (1,137) (411) (2,051) (1,213)
Profit before income taxes 1,275 3,515 7,636 11,772
Income tax (benefit) expense (108) 982 1,000 3,894
Net earnings 1,383 2,533 6,636 7,878
Less: Net earnings attributable to the non-controlling interest 29 12 81 151
Net earnings attributable to Kewaunee Scientific Corporation $ 1,354 $ 2,521 $ 6,555 $ 7,727
Net earnings per share attributable to Kewaunee Scientific Corporation stockholders        
Basic (in dollars per share) $ 0.47 $ 0.87 $ 2.29 $ 2.68
Diluted (in dollars per share) $ 0.45 $ 0.85 $ 2.20 $ 2.64
Weighted average number of common shares outstanding        
Basic (in shares) 2,872 2,893 2,864 2,885
Diluted (in shares) 2,995 2,965 2,979 2,927